Northern Trust’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-102,282
| Closed | -$2.76M | – | 4659 |
|
|
2022
Q4 | $2.76M | Buy |
102,282
+3,549
| +4% | +$93.4K | ﹤0.01% | 2827 |
|
|
2022
Q3 | $1.77M | Buy |
98,733
+128
| +0.1% | +$2.04K | ﹤0.01% | 3078 |
|
|
2022
Q2 | $1.23M | Buy |
98,605
+7,027
| +8% | +$77.5K | ﹤0.01% | 3286 |
|
|
2022
Q1 | $1.22M | Sell |
91,578
-1,646
| -2% | -$22.1K | ﹤0.01% | 3336 |
|
|
2021
Q4 | $1.45M | Sell |
93,224
-231
| -0.2% | -$4.41K | ﹤0.01% | 3390 |
|
|
2021
Q3 | $2.1M | Buy |
93,455
+2,929
| +3% | +$64.3K | ﹤0.01% | 3265 |
|
|
2021
Q2 | $2.06M | Buy |
90,526
+892
| +1% | +$18.8K | ﹤0.01% | 3342 |
|
|
2021
Q1 | $1.84M | Buy |
89,634
+79,471
| +782% | +$1.81M | ﹤0.01% | 3286 |
|
|
2020
Q4 | $281K | Sell |
10,163
-7
| -0.1% | -$136 | ﹤0.01% | 3884 |
|
|
2020
Q3 | $143K | Buy |
10,170
+12
| +0.1% | +$223 | ﹤0.01% | 3882 |
|
|
2020
Q2 | $209K | Sell |
10,158
-126
| -1% | -$1.71K | ﹤0.01% | 3750 |
|
|
2020
Q1 | $78K | Buy |
10,284
+173
| +2% | +$1.94K | ﹤0.01% | 3870 |
|
|
2019
Q4 | $157K | Sell |
10,111
-1,403
| -12% | -$14.1K | ﹤0.01% | 3850 |
|
|
2019
Q3 | $59K | Sell |
11,514
-1
| -0% | -$7 | ﹤0.01% | 4032 |
|
|
2019
Q2 | $105K | Buy |
+11,515
| New | +$172K | ﹤0.01% | 3966 |
|
|
2018
Q4 | – | Sell |
-29,847
| Closed | -$792K | – | 4324 |
|
|
2018
Q3 | $792K | Buy |
+29,847
| New | +$675K | ﹤0.01% | 3531 |
|
|
2017
Q2 | – | Sell |
-83,593
| Closed | -$981K | – | 4312 |
|
|
2017
Q1 | $981K | Buy |
83,593
+2,948
| +4% | +$33.8K | ﹤0.01% | 3356 |
|
|
2016
Q4 | $1M | Buy |
+80,645
| New | +$934K | ﹤0.01% | 3349 |
|
Other funds holding MYOV
Northern Trust's MYOV Position: Q1 2023 in Review
Northern Trust sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 102,282 shares — an estimated $2.76M sold.
Northern Trust first reported a position in MYOV in Q4 2016 and held it in 18 quarters. The position peaked at $2.76M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- Northern Trust reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- Northern Trust sold 102,282 Myovant Sciences Ltd. shares in Q1 2023, an estimated $2.76M.
- Northern Trust first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 18 quarters.
- Northern Trust's Myovant Sciences Ltd. position peaked at $2.76M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.